Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Illumina, a developer, manufacturer and marketer of life-science tools, has introduced GenomeStudio software, a primary analysis software program designed to analyze both microarray and sequencing data.
Subscribe to our email newsletter
For researchers, GenomeStudio software enables the correlation of biological variation across multiple applications and graphical display of the results. The flexibility of GenomeStudio software also allows researchers to integrate with third-party software providers for advanced downstream analysis, said Illumina. GenomeStudio software will be broadly available to researchers in November 2008.
In addition to algorithms for copy number variation detection, single-nucleotide polymorphism calling, and differential analysis, GenomeStudio software contains tools for visualizing sequencing data that are fueled by a new and expanded version of Illumina’s Genome Analyzer Analysis Pipeline, added Illumina.
A new processing module known as CASAVA (Consensus Assessment of Sequence and Variation) allows users to detect sequence variants from one or more Genome Analyzer sequencing runs. According to the company, these new features allow users to align reads directly to sequences representing processed RNAs, and identify and quantify genes, exons and splice junctions. Results are imported directly into GenomeStudio software for visual and graphical analysis.
Greg May, director of the Genome Center at the National Center for Genetic Research, said: “GenomeStudio software allows us to see meaningful changes in RNA processing and will allow us to further unravel the complexities of transcriptional regulation in complex conditions such as schizophrenia and sepsis, a blood poisoning disease.”